JP2007527900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007527900A5 JP2007527900A5 JP2007502342A JP2007502342A JP2007527900A5 JP 2007527900 A5 JP2007527900 A5 JP 2007527900A5 JP 2007502342 A JP2007502342 A JP 2007502342A JP 2007502342 A JP2007502342 A JP 2007502342A JP 2007527900 A5 JP2007527900 A5 JP 2007527900A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- methoxy
- hexahydrophenanthridin
- 4ars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000001257 hydrogen Substances 0.000 claims 51
- 229910052739 hydrogen Inorganic materials 0.000 claims 51
- -1 2,2-difluoroethoxy Chemical group 0.000 claims 26
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 14
- 150000002431 hydrogen Chemical class 0.000 claims 12
- 150000001204 N-oxides Chemical class 0.000 claims 11
- 229910052757 nitrogen Inorganic materials 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 239000011737 fluorine Substances 0.000 claims 4
- 229910052731 fluorine Inorganic materials 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 208000023504 respiratory system disease Diseases 0.000 claims 2
- 229910052717 sulfur Chemical group 0.000 claims 2
- 239000011593 sulfur Chemical group 0.000 claims 2
- LGHMEPPEZLGICK-XFQXTVEOSA-N (2r,4ar,10br)-9-ethoxy-8-methoxy-6-(4-methylsulfanylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound N([C@@H]1CC[C@@H](O)C[C@@H]1C=1C=C(C(=CC=11)OC)OCC)=C1C1=CC=C(SC)C=C1 LGHMEPPEZLGICK-XFQXTVEOSA-N 0.000 claims 1
- TVBOYUWMRQNCKY-UHFFFAOYSA-N 4-(2-hydroxy-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl)-n,n-dipropylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(CCC)CCC)=CC=C1C(C1=CC(OC)=C(OC)C=C11)=NC2C1CC(O)CC2 TVBOYUWMRQNCKY-UHFFFAOYSA-N 0.000 claims 1
- ZLNKCILVUPCDMK-UHFFFAOYSA-N 4-(9-ethoxy-2-hydroxy-8-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl)-n-(2-methoxyethyl)-n-methylbenzenesulfonamide Chemical compound C1=2C=C(OC)C(OCC)=CC=2C2CC(O)CCC2N=C1C1=CC=C(S(=O)(=O)N(C)CCOC)C=C1 ZLNKCILVUPCDMK-UHFFFAOYSA-N 0.000 claims 1
- YKYBWJPJPYUMMX-UHFFFAOYSA-N 4-[8-(difluoromethoxy)-2-hydroxy-9-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl]-n,n-dipropylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(CCC)CCC)=CC=C1C(C1=CC(OC(F)F)=C(OC)C=C11)=NC2C1CC(O)CC2 YKYBWJPJPYUMMX-UHFFFAOYSA-N 0.000 claims 1
- FPZPVAPRNYQXEV-UHFFFAOYSA-N 4-fluoro-n-[4-(2-hydroxy-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl)phenyl]benzenesulfonamide Chemical compound C1=2C=C(OC)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(F)C=C1 FPZPVAPRNYQXEV-UHFFFAOYSA-N 0.000 claims 1
- AIXUMCSAWMORJJ-UHFFFAOYSA-N 8,9-dimethoxy-6-(3-methylsulfonylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound C1=2C=C(OC)C(OC)=CC=2C2CC(O)CCC2N=C1C1=CC=CC(S(C)(=O)=O)=C1 AIXUMCSAWMORJJ-UHFFFAOYSA-N 0.000 claims 1
- VEYGYIUBIIUIOO-UHFFFAOYSA-N 8-(difluoromethoxy)-9-methoxy-6-(3-morpholin-4-ylsulfonylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=1)=CC=CC=1S(=O)(=O)N1CCOCC1 VEYGYIUBIIUIOO-UHFFFAOYSA-N 0.000 claims 1
- FUNLWRBTQMXPDS-UHFFFAOYSA-N 8-(difluoromethoxy)-9-methoxy-6-(3-piperidin-1-ylsulfonylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=1)=CC=CC=1S(=O)(=O)N1CCCCC1 FUNLWRBTQMXPDS-UHFFFAOYSA-N 0.000 claims 1
- PUWZSYQMTRFIOS-UHFFFAOYSA-N 8-(difluoromethoxy)-9-methoxy-6-(3-pyrrolidin-1-ylsulfonylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=1)=CC=CC=1S(=O)(=O)N1CCCC1 PUWZSYQMTRFIOS-UHFFFAOYSA-N 0.000 claims 1
- KQFPMOUKQAALNS-UHFFFAOYSA-N 8-(difluoromethoxy)-9-methoxy-6-(4-pyrrolidin-1-ylsulfonylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1)=CC=C1S(=O)(=O)N1CCCC1 KQFPMOUKQAALNS-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- AAHXSKMTZNLLDS-UHFFFAOYSA-N 9-(2,2-difluoroethoxy)-8-methoxy-6-(3-methylsulfinylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound N=1C2CCC(O)CC2C=2C=C(OCC(F)F)C(OC)=CC=2C=1C1=CC=CC(S(C)=O)=C1 AAHXSKMTZNLLDS-UHFFFAOYSA-N 0.000 claims 1
- CTMIWKUQCCVGMQ-UHFFFAOYSA-N 9-(2,2-difluoroethoxy)-8-methoxy-6-(4-methylsulfanylphenyl)-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol Chemical compound N=1C2CCC(O)CC2C=2C=C(OCC(F)F)C(OC)=CC=2C=1C1=CC=C(SC)C=C1 CTMIWKUQCCVGMQ-UHFFFAOYSA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- NGYRGWAKJULXKZ-UHFFFAOYSA-N n-[4-(2-hydroxy-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl)-2-methylphenyl]-4-methylbenzenesulfonamide Chemical compound C1=2C=C(OC)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1C)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 NGYRGWAKJULXKZ-UHFFFAOYSA-N 0.000 claims 1
- WJALITREPKNFHM-UHFFFAOYSA-N n-[4-(2-hydroxy-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl)phenyl]-4-methylbenzenesulfonamide Chemical compound C1=2C=C(OC)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 WJALITREPKNFHM-UHFFFAOYSA-N 0.000 claims 1
- TZWQEFCHDOOVRJ-UHFFFAOYSA-N n-[4-(2-hydroxy-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl)phenyl]-n,4-dimethylbenzenesulfonamide Chemical compound C1=2C=C(OC)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1)=CC=C1N(C)S(=O)(=O)C1=CC=C(C)C=C1 TZWQEFCHDOOVRJ-UHFFFAOYSA-N 0.000 claims 1
- OUBMTAUZCZAKCX-UHFFFAOYSA-N n-[4-[8-(difluoromethoxy)-2-hydroxy-9-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl]phenyl]-4-methylbenzenesulfonamide Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 OUBMTAUZCZAKCX-UHFFFAOYSA-N 0.000 claims 1
- JFEPOSTVNXVXMR-UHFFFAOYSA-N n-[4-[8-(difluoromethoxy)-2-hydroxy-9-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl]phenyl]methanesulfonamide Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C1=CC=C(NS(C)(=O)=O)C=C1 JFEPOSTVNXVXMR-UHFFFAOYSA-N 0.000 claims 1
- ZMXXNGCADPTWAQ-UHFFFAOYSA-N n-[4-[9-(difluoromethoxy)-2-hydroxy-8-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl]phenyl]-4-methylbenzenesulfonamide Chemical compound N=1C2CCC(O)CC2C=2C=C(OC(F)F)C(OC)=CC=2C=1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 ZMXXNGCADPTWAQ-UHFFFAOYSA-N 0.000 claims 1
- WIQVBNVCSXRDET-UHFFFAOYSA-N n-[[4-(2-hydroxy-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl)phenyl]methyl]-4-methylbenzenesulfonamide Chemical compound C1=2C=C(OC)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1)=CC=C1CNS(=O)(=O)C1=CC=C(C)C=C1 WIQVBNVCSXRDET-UHFFFAOYSA-N 0.000 claims 1
- QZZRXLYUGXDACT-UHFFFAOYSA-N n-[[4-[8-(difluoromethoxy)-2-hydroxy-9-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl]phenyl]methyl]-4-methylbenzenesulfonamide Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=C1)=CC=C1CNS(=O)(=O)C1=CC=C(C)C=C1 QZZRXLYUGXDACT-UHFFFAOYSA-N 0.000 claims 1
- LVRGSLAOKXFTHB-UHFFFAOYSA-N n-cyclopropyl-3-[8-(difluoromethoxy)-2-hydroxy-9-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-6-yl]benzenesulfonamide Chemical compound C1=2C=C(OC(F)F)C(OC)=CC=2C2CC(O)CCC2N=C1C(C=1)=CC=CC=1S(=O)(=O)NC1CC1 LVRGSLAOKXFTHB-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical group C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04100988 | 2004-03-10 | ||
| EP05100692 | 2005-02-01 | ||
| PCT/EP2005/051052 WO2005087744A1 (en) | 2004-03-10 | 2005-03-09 | Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007527900A JP2007527900A (ja) | 2007-10-04 |
| JP2007527900A5 true JP2007527900A5 (https=) | 2008-04-24 |
Family
ID=34961402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007502342A Withdrawn JP2007527900A (ja) | 2004-03-10 | 2005-03-09 | チオ含有の新規のヒドロキシ−６−フェニルフェナントリジン及びｐｄｅ４インヒビターとしてのそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080161339A1 (https=) |
| EP (1) | EP1725533A1 (https=) |
| JP (1) | JP2007527900A (https=) |
| KR (1) | KR20060124783A (https=) |
| AR (1) | AR048001A1 (https=) |
| AU (1) | AU2005221831A1 (https=) |
| BR (1) | BRPI0508473A (https=) |
| CA (1) | CA2558390A1 (https=) |
| IL (1) | IL177499A0 (https=) |
| NO (1) | NO20064416L (https=) |
| TW (1) | TW200540159A (https=) |
| WO (1) | WO2005087744A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE353217T1 (de) | 2002-08-29 | 2007-02-15 | Altana Pharma Ag | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren |
| CA2556086C (en) | 2004-02-18 | 2014-04-01 | Altana Pharma Ag | Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| PL2589599T4 (pl) | 2004-03-03 | 2015-06-30 | Takeda Gmbh | Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4 |
| EP1725534A1 (en) * | 2004-03-10 | 2006-11-29 | Altana Pharma AG | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
| PL1856093T3 (pl) | 2005-03-02 | 2010-05-31 | Takeda Gmbh | Chlorowodorek (2R,4aR,10bR)-6-(2,6-dimetoksy-pirydyn-3-ylo)-9-etoksy-8-metoksy-1,2,3,4,4a,10b-heksahydrofenantrydyn-2-olu |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| JP2010508315A (ja) | 2006-10-30 | 2010-03-18 | ノバルティス アーゲー | 抗炎症剤としてのヘテロ環式化合物 |
| ES2460897T3 (es) | 2007-10-04 | 2014-05-14 | F. Hoffmann-La Roche Ag | Derivados de ciclopropil aril amida y usos de los mismos |
| AU2009203693B2 (en) | 2008-01-11 | 2012-06-07 | Novartis Ag | Pyrimidines as kinase inhibitors |
| UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| MA34969B1 (fr) | 2011-02-25 | 2014-03-01 | Irm Llc | Composes et compositions en tant qu inibiteurs de trk |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9707233A (pt) * | 1996-01-31 | 1999-07-20 | Byk Gulden Lomberg Chem Fab | Fenantridinas |
| US6127378A (en) * | 1996-03-26 | 2000-10-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines substituted in the 6 position |
| SI0889886T1 (en) * | 1996-03-26 | 2003-02-28 | Altana Pharma Ag | Novel phenanthridines substituted in the 6 position |
| PT998460E (pt) * | 1997-07-25 | 2004-07-30 | Altana Pharma Ag | Novos derivados de tetrazole |
| JP2001510827A (ja) * | 1997-07-25 | 2001-08-07 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 置換６−フェニルフェナントリジン |
| DK1075477T3 (da) * | 1998-05-05 | 2003-06-30 | Altana Pharma Ag | Nye benzonaphthyridin-N-oxider |
| TR200501553T2 (tr) * | 1999-01-15 | 2005-06-21 | Altana Pharma Ag | PDE-IV inhibe edici aktivitesi olan fenilfenantridinler |
| JP4587294B2 (ja) * | 2002-08-29 | 2010-11-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４インヒビターとしての２−ヒドロキシ−６−フェニルフェナントリジン |
-
2005
- 2005-03-09 CA CA002558390A patent/CA2558390A1/en not_active Abandoned
- 2005-03-09 KR KR1020067020591A patent/KR20060124783A/ko not_active Withdrawn
- 2005-03-09 AU AU2005221831A patent/AU2005221831A1/en not_active Abandoned
- 2005-03-09 JP JP2007502342A patent/JP2007527900A/ja not_active Withdrawn
- 2005-03-09 EP EP05716969A patent/EP1725533A1/en not_active Withdrawn
- 2005-03-09 US US10/591,768 patent/US20080161339A1/en not_active Abandoned
- 2005-03-09 WO PCT/EP2005/051052 patent/WO2005087744A1/en not_active Ceased
- 2005-03-09 BR BRPI0508473-3A patent/BRPI0508473A/pt not_active IP Right Cessation
- 2005-03-10 AR ARP050100916A patent/AR048001A1/es unknown
- 2005-03-10 TW TW094107371A patent/TW200540159A/zh unknown
-
2006
- 2006-08-15 IL IL177499A patent/IL177499A0/en unknown
- 2006-09-29 NO NO20064416A patent/NO20064416L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12391663B2 (en) | Isoindolinone compounds | |
| JP2007527900A5 (https=) | ||
| JP7724394B2 (ja) | イソインドリノン化合物 | |
| JP5843861B2 (ja) | Ａｘｌ阻害剤としての薬学的に活性な化合物 | |
| EP4129295A1 (en) | Pharmaceutical composition for prevention or treatment of cancers associated with kras mutation | |
| US10058534B2 (en) | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders | |
| JP2016525075A5 (https=) | ||
| JP2017525757A5 (https=) | ||
| JP2004536066A5 (https=) | ||
| CN107406438A (zh) | 溴结构域的抑制剂 | |
| JPWO2007063925A1 (ja) | ２−アミノベンズアミド誘導体 | |
| JP2020502092A5 (https=) | ||
| JP2006206609A5 (https=) | ||
| JP2007523152A5 (https=) | ||
| JP2011521938A5 (https=) | ||
| EP4323349A1 (en) | Isoindolinone amide compounds useful to treat diseases associated with gspt1 | |
| RU2008122405A (ru) | Замещенные производные циннолина в качестве модуляторов гамма-рецепторов и способ их синтеза | |
| RU2014148316A (ru) | Производные 1-фенил-2-пиридинил-алкиловых спиртов в качестве ингибиторов фосфодиэстеразы | |
| JP2009520021A5 (https=) | ||
| JP2007506703A (ja) | Ｐｄｅ４阻害剤としての４−アミノキノリン−３−カルボキサミド誘導体 | |
| JP2019537581A5 (https=) | ||
| WO2016140973A1 (en) | Quinolinones as inhibitors of translation initiation complex | |
| JP2007527898A5 (https=) | ||
| JP2008526818A5 (https=) | ||
| JP2023526332A5 (https=) |